Patented Medicine Prices Review Board – December 9, 2002 Meeting
At its meeting, the Board:
- Considered the Report of the Working Group on Price Review Issues on the price Guidelines for category 3 new drug products.
- Received staff briefings on
- ongoing initiatives under the National Prescription Drug Utilization Information System (NPDUIS);
- the study on the Prices of the Top Selling Multiple Source Medicines in Canada, prepared by the PMPRB for the Federal/Provincial/Territorial Working Group on Drug Prices;
- the study, A Comparison of Pharmaceutical R&D Spending in Canada and Selected Countries;
- the study on Foreign Price Trends for Patented Medicines; and
- the report of the Commission on the Future of Health Care in Canada, released November 28, 2002.
The next Board meeting is scheduled for February 10, 2003.
For any additional information, please contact the Secretary of the Board at
